Study reveals new aptamer targeting tool can detect early signs of motor neurone disease
The fatal, progressive neurological condition currently affects around 5,000 people in the UK
Read More
Tag: aptamer
BaseCure collaborates with Aptamer Group to boost gene therapies
Binders will establish cell types and delivery vehicles may increase uptake of the siRNA therapy
Read More
- Ipsen announces new data on Dysport in neurological disease
- PMGroup Worldwide Ltd welcomes MAD World Summit
- Argenx receives review from FDA for VYVGART in seronegative gMG
- Nuclera extends Series C funding to advance antibody engineering
- Cellistic launches new iPSC-based platforms to expand immuno-oncology therapies
